| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |